Solution Structure of Human Survivin and Its Binding Interface with Smac/Diablo
Author:
Affiliation:
1. Global Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, Illinois 60064
Publisher
American Chemical Society (ACS)
Subject
Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/bi0485171
Reference37 articles.
1. Validating survivin as a cancer therapeutic target
2. IAP proteins: blocking the road to death's door
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Survivin as a Therapeutic Target for the Treatment of Human Cancer;Cancers;2024-04-27
2. Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer;Medical Oncology;2024-03-28
3. Targeting survivin for cancer therapy: Strategies, small molecule inhibitors and vaccine based therapeutics in development;Life Sciences;2023-12
4. Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study;Journal of Biomolecular Structure and Dynamics;2023-09-28
5. Survivin prevents the polycomb repressor complex 2 from methylating histone 3 lysine 27;iScience;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3